- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy in psoriasis
Authors
Keywords
-
Journal
Immunotherapy
Volume 13, Issue 7, Pages 605-619
Publisher
Future Medicine Ltd
Online
2021-04-06
DOI
10.2217/imt-2020-0292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The current landscape of psoriasis genetics in 2020
- (2020) Kotaro Ogawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
- (2020) Paolo Gisondi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Should biologics for psoriasis be interrupted in the era of COVID-19?
- (2020) Mark Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
- (2020) Amene Saghazadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
- (2020) Michael P. Schön et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic
- (2020) Payal Shah et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment discontinuation and rate of disease transmission in psoriasis patients on biologic therapy during the COVID-19 pandemic – A Canadian Multicenter Retrospective Study
- (2020) Jorge R. Georgakopoulos et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Second-Strand Synthesis-Based Massively Parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin Pathologies
- (2020) Travis K. Hughes et al. IMMUNITY
- IL-17E (IL-25) enhances innate immune responses during skin inflammation
- (2019) Luisa Senra et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Biologics switch in psoriasis
- (2019) Ting-Shun Wang et al. Immunotherapy
- Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon
- (2019) Kazuhisa Furue et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
- (2019) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- T cell pathology in skin inflammation
- (2019) Robert Sabat et al. Seminars in Immunopathology
- Biosimilars for the treatment of psoriasis
- (2019) Lluís Puig et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course
- (2019) Kazuo Kurihara et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial
- (2019) Kristian Reich et al. LANCET
- Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response
- (2019) Laura M. Sawyer et al. PLoS One
- Integrated microRNA/mRNA expression profiling of the skin of psoriasis patients
- (2019) Denis Delić et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- IL‐17C amplifies epithelial inflammation in human psoriasis and atopic eczema
- (2019) F. Lauffer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
- (2018) A. Egeberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17
- (2018) L.H. Eaton et al. BRITISH JOURNAL OF DERMATOLOGY
- The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review
- (2018) Cæcilie Johansen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop
- (2018) Yuriko Hashiguchi et al. JOURNAL OF IMMUNOLOGY
- Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2018) Ireny Y.K. Iskandar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical Outcome
- (2018) Irène Gallais Sérézal et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CME Part I Psoriasis: Which Therapy for Which Patient Psoriasis comorbidities and preferred systemic agents
- (2018) Shivani B. Kaushik et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study
- (2018) L. Iversen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Psoriasis and infection. A clinical practice narrative
- (2018) Marius Rademaker et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- The effect of Adalimumab on the vasculature in psoriatic skin lesions
- (2018) S.C.A Hanssen et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
- (2018) Nicolo Costantino Brembilla et al. Frontiers in Immunology
- Biologics and Psoriasis
- (2018) Hee J. Kim et al. DERMATOLOGIC CLINICS
- Biological Effects of IL-26 on T Cell–Mediated Skin Inflammation, Including Psoriasis
- (2018) Takumi Itoh et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation
- (2017) Jérôme C. Martin et al. JOURNAL OF IMMUNOLOGY
- Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome
- (2017) Milton José Max Rodríguez-Zúñiga et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial
- (2017) Kristian Reich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Richard B Warren et al. LANCET
- Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
- (2017) Kristin K Jørgensen et al. LANCET
- Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ
- (2017) Joseph S. Ainscough et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy
- (2016) Florenzo Iannone et al. AUTOIMMUNITY REVIEWS
- Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology
- (2016) Lilla Landeck et al. EXPERIMENTAL DERMATOLOGY
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- Pathogenese der Psoriasis vulgaris
- (2016) K. Schäkel et al. HAUTARZT
- Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer
- (2016) Charlene Porter et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2015) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
- (2015) Diamant Thaçi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC
- (2015) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Industry–academia collaborations for biomarkers
- (2015) Khusru Asadullah et al. NATURE REVIEWS DRUG DISCOVERY
- A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
- (2015) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fumaderm®in daily practice for psoriasis: dosing, efficacy and quality of life
- (2014) F. Walker et al. BRITISH JOURNAL OF DERMATOLOGY
- Psoriasis and risk of heart failure: a nationwide cohort study
- (2014) Usman Khalid et al. EUROPEAN JOURNAL OF HEART FAILURE
- IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
- (2014) Ellen Witte et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumor Necrosis Factor Receptor Signaling in Keratinocytes Triggers Interleukin-24-Dependent Psoriasis-like Skin Inflammation in Mice
- (2013) Snehlata Kumari et al. IMMUNITY
- Therapeutic opportunities of the IL-22–IL-22R1 system
- (2013) Robert Sabat et al. NATURE REVIEWS DRUG DISCOVERY
- IL-29 Is Produced by TH17 Cells and Mediates the Cutaneous Antiviral Competence in Psoriasis
- (2013) K. Wolk et al. Science Translational Medicine
- The Antimicrobial Protein REG3A Regulates Keratinocyte Proliferation and Differentiation after Skin Injury
- (2012) Yuping Lai et al. IMMUNITY
- A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions
- (2012) Tina Bhutani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011
- (2012) April W. Armstrong et al. PLoS One
- Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
- (2011) B. B. Aggarwal et al. BLOOD
- Increased risk of infectious disease requiring hospitalization among patients with psoriasis: A population-based cohort
- (2011) Marlies Wakkee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesit
- (2011) Philip J. Mease ARTHRITIS CARE & RESEARCH
- Definition of treatment goals for moderate to severe psoriasis: a European consensus
- (2010) U. Mrowietz et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis
- (2009) Kerstin Wolk et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Komorbiditäten bei Psoriasis vulgaris
- (2009) W.-H. Boehncke et al. HAUTARZT
- IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not
- (2009) Kerstin Wolk et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis
- (2009) Robin J. Bell et al. SUPPORTIVE CARE IN CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search